Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization Sort ascending
Dec
29
2020
Saga of “Most Favored Nations” Giordano, Halleran & Ciesla, P.C.
Aug
29
2013
New Jersey Spill Act Claim Subject To Statute Of Limitations Giordano, Halleran & Ciesla, P.C.
Jan
14
2014
Extension of 2012 Water Quality Planning Act Sent to Governor Christie of New Jersey Giordano, Halleran & Ciesla, P.C.
Mar
9
2022
January 2022 State Regulatory Developments Giordano, Halleran & Ciesla, P.C.
Feb
19
2014
Middlesex County Sewer Service Area Update Delayed Giordano, Halleran & Ciesla, P.C.
Oct
7
2014
New Jersey Appellate Division Holds That Applicants for a Professional License Need Not Exhibit an Intent To Deceive In Order To Have Their License Application Denied Due To Misrepresentation Giordano, Halleran & Ciesla, P.C.
May
16
2017
Medical Marijuana in the New Jersey Workplace Giordano, Halleran & Ciesla, P.C.
Jun
26
2013
New Jersey Senate Passes Open-Space Preservation Amendment Giordano, Halleran & Ciesla, P.C.
Aug
18
2014
Office of Inspector General (OIG) Issues Unfavorable Advisory Opinion to Specialty Pharmacy For Support Service Payments Giordano, Halleran & Ciesla, P.C.
Sep
19
2014
Internet/Social Media Platforms: FDA Draft Guidance Giordano, Halleran & Ciesla, P.C.
Aug
4
2019
Pharmaceutical Importations Giordano, Halleran & Ciesla, P.C.
Jul
12
2013
Senate Bill Would Increase Pipeline and Hazardous Materials Safety Administration (PHMSA) Budget by Over 12 Percent Barnes & Thornburg LLP
Aug
16
2013
New All Appropriate Inquiries (ASTM) Phase 1 Environmental Site Assessment Standards Endorsed by EPA as Constituting “All Appropriate Inquiries” under Comprehensive Environmental Response, Compensation and Liability Act (CERCLA) Barnes & Thornburg LLP
Jul
3
2018
FDA Issues First Installment Of Guidance On ‘Mitigation Strategies To Protect Food Against Intentional Adulteration’ Rule Barnes & Thornburg LLP
Jan
3
2019
2018 Year-End FDA Medical Device Highlights Include Proposed Changes Barnes & Thornburg LLP
Feb
22
2019
Insurance Coverage for Defendants Named in Nationwide Opioid Litigation Barnes & Thornburg LLP
Oct
21
2014
FDA Issues Final Guidance on Distinguishing Medical Device Recall from Product Enhancement Barnes & Thornburg LLP
Dec
18
2014
2014 Interim Guidance on Patent Subject Matter Eligibility Under Myriad and Nature-Based Products Barnes & Thornburg LLP
Jan
20
2015
FDA Issues Draft Guidance on Policy for Low Risk Devices for General Wellness Barnes & Thornburg LLP
Jul
27
2015
FDA Issues Proposed Rule and Draft Guidance on User Fee Program for Accreditation of Third-Party Auditors-Certification Bodies to Conduct Food Safety Audits and To Issue Certifications Barnes & Thornburg LLP
Nov
30
2015
Food Safety and Inspection Service Issues New Allergen Handling Guidelines Barnes & Thornburg LLP
Jan
12
2016
FDA Issues Draft Guidance on Emerging Signals for Medical Devices Barnes & Thornburg LLP
May
28
2023
New Consumer Product Safety Regulations In The EU Barnes & Thornburg LLP
May
17
2016
FDA Issues Draft Guidance on Additive Manufacturing Including 3D Printing Barnes & Thornburg LLP
Apr
21
2020
California Requires COVID-19 Supplemental Paid Sick Leave for Food Sector Workers Barnes & Thornburg LLP
Apr
16
2018
Congress Takes on Opioid Epidemic, Aims to Provide Tools for Public Health Barnes & Thornburg LLP
Dec
1
2021
CMS Vaccine Mandate Faces Nationwide Preliminary Injunction Barnes & Thornburg LLP
Jan
10
2022
Will A Starbucks Union Affect Your Morning Cup Of Coffee? Barnes & Thornburg LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins